Subject of the day
BICO.ST
BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through two segments: Life Science Solutions and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables and applications in cell culture, cell imaging, cell sorting, and sample preparation for different analytics, such as genomics, as well as offers instruments and solutions for the manufacturing of diagnostics, as well as consumables. The Lab Automation segment provides the proprietary and hardware-agnostic Green Button Go Suite software for connected workflows, as well as automation technology integration, and consulting and engineering services to design, build, and install automated laboratory systems. In addition, the company offers a range of services and consumables such as reagents, bioinks, plates, and tissue models. It serves pharma and biopharma, biotech, diagnostics, academia and research, and cosmetic industries. The company offers its products through sales organizations, as well as through distributor network. BICO Group AB (publ) was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. The company was incorporated in 2016 and is headquartered in Gothenburg, Sweden.
| Line | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | $334.70M | $324.20M | $451.30M | $329.90M |
| Gross profit | $189.70M | $142.40M | $235.40M | $178.60M |
| Operating income | -$77.90M | -$105.50M | -$19.30M | -$91.20M |
| Net income | -$233.90M | -$184.20M | -$59.20M | -$131.30M |
| Diluted EPS | -3.31 | -2.61 | -0.84 | -1.86 |
| Free cash flow | $70.40M | -$34.00M | $46.30M | $42.30M |
| CapEx | -$6.20M | -$5.80M | -$5.20M | -$5.00M |
$16.26
▼ -0.38 (-2.3%)
| 52w hi | $35.30 |
|---|---|
| 52w lo | $13.00 |
| Vol | 198.41K |
| As of | Aug 13 |
Our score -0.16
| Short | +0.01 |
|---|---|
| Medium | -0.06 |
| Long | -0.69 |
computed 2026-08-13
BICO Group AB (publ)
Healthcare · Medical Devices
| Market cap | $1.15B |
|---|---|
| Enterprise value | $1.12B |
| Trailing P/E | — |
| Forward P/E | -30.68x |
| EV / EBITDA | -8.30x |
| P / S (ttm) | 0.77x |
| Profit margin | -66.1% |
| Return on equity | -69.3% |
| Revenue growth | -1.4% |
| Earnings growth | — |
| Debt / equity | 42.93 |
| Beta vs SPX | 0.40 |
|---|---|
| Corr SPX | 0.11 |
| Annual vol | 63.5% |
| Annual ret | -18.3% |
| Sharpe | -0.29 |
| Max DD | -72.8% |
Window: 504 trading days (490 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.19 | |
| Sector | +0.12 | |
| Technical | +0.00 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $17.00 | $17.00 | $16.12 | $16.26 | 198.41K |
| Aug 12 | $17.12 | $17.12 | $16.22 | $16.64 | 279.30K |
| Aug 11 | $16.00 | $17.22 | $15.74 | $17.12 | 674.42K |
| Aug 10 | $15.38 | $16.00 | $15.24 | $16.00 | 237.04K |
| Aug 7 | $15.06 | $15.64 | $15.00 | $15.38 | 153.09K |